Literature DB >> 21654194

From Plk1 to Plk5: functional evolution of polo-like kinases.

Guillermo de Cárcer1, Gerard Manning, Marcos Malumbres.   

Abstract

Mammalian polo-like kinases (Plks) are characterized by the presence of an N-terminal protein kinase domain and a C-terminal polo-box domain (PBD) involved in substrate binding and regulation of kinase activity. Plk1-4 have traditionally been linked to cell cycle progression, genotoxic stress and, more recently, neuron biology. Recently, a fifth mammalian Plk family member, Plk5, has been characterized in murine and human cells. Plk5 is expressed mainly in differentiated tissues such as the cerebellum. Despite apparent loss of catalytic activity and a stop codon in the middle of the human gene, Plk5 proteins retain important functions in neuron biology. Notably, its expression is silenced by epigenetic alterations in brain tumors, such as glioblastomas, and its re-expression prevents cell proliferation of these tumor cells. In this review, we will focus on the non-cell cycle roles of Plks, the biology of the new member of the family and the possible kinase- and PBD-independent functions of polo-like kinases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654194      PMCID: PMC3230524          DOI: 10.4161/cc.10.14.16494

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  83 in total

Review 1.  Polo-like kinases in the nervous system.

Authors:  Daniel P Seeburg; Daniel Pak; Morgan Sheng
Journal:  Oncogene       Date:  2005-01-10       Impact factor: 9.867

Review 2.  A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy.

Authors:  Ignacio Pérez de Castro; Guillermo de Cárcer; Marcos Malumbres
Journal:  Carcinogenesis       Date:  2007-01-27       Impact factor: 4.944

3.  Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.

Authors:  Leonidas Benetatos; Aggeliki Dasoula; Eleftheria Hatzimichael; Nelofer Syed; Maria Voukelatou; George Dranitsaris; Konstantinos L Bourantas; Tim Crook
Journal:  Ann Hematol       Date:  2011-02-22       Impact factor: 3.673

4.  Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway.

Authors:  S Xie; H Wu; Q Wang; J P Cogswell; I Husain; C Conn; P Stambrook; M Jhanwar-Uniyal; W Dai
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

5.  Functional whole-genome analysis identifies Polo-like kinase 2 and poliovirus receptor as essential for neuronal differentiation upstream of the negative regulator alphaB-crystallin.

Authors:  Cristina Draghetti; Catherine Salvat; Francisca Zanoguera; Marie-Laure Curchod; Chloé Vignaud; Helene Peixoto; Alessandro Di Cara; David Fischer; Mohanraj Dhanabal; Goutopoulos Andreas; Hadi Abderrahim; Christian Rommel; Montserrat Camps
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

6.  Targeted protein degradation and synapse remodeling by an inducible protein kinase.

Authors:  Daniel T S Pak; Morgan Sheng
Journal:  Science       Date:  2003-10-23       Impact factor: 47.728

7.  Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2.

Authors:  Suqing Xie; Huiyun Wu; Qi Wang; Jan Kunicki; Raymond O Thomas; Robert E Hollingsworth; John Cogswell; Wei Dai
Journal:  Cell Cycle       Date:  2002 Nov-Dec       Impact factor: 4.534

8.  SAK/PLK4 is required for centriole duplication and flagella development.

Authors:  M Bettencourt-Dias; A Rodrigues-Martins; L Carpenter; M Riparbelli; L Lehmann; M K Gatt; N Carmo; F Balloux; G Callaini; D M Glover
Journal:  Curr Biol       Date:  2005-12-01       Impact factor: 10.834

9.  Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation.

Authors:  Benjamin A Wolfe; Tohru Takaki; Mark Petronczki; Michael Glotzer
Journal:  PLoS Biol       Date:  2009-05-26       Impact factor: 8.029

10.  Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.

Authors:  Rüdiger Neef; Christian Preisinger; Josephine Sutcliffe; Robert Kopajtich; Erich A Nigg; Thomas U Mayer; Francis A Barr
Journal:  J Cell Biol       Date:  2003-08-25       Impact factor: 10.539

View more
  115 in total

Review 1.  Functions and regulation of the Polo-like kinase Cdc5 in the absence and presence of DNA damage.

Authors:  Vladimir V Botchkarev; James E Haber
Journal:  Curr Genet       Date:  2017-08-02       Impact factor: 3.886

2.  Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation.

Authors:  Long Chen; Zhiguo Li; Nihal Ahmad; Xiaoqi Liu
Journal:  Biochemistry       Date:  2015-04-06       Impact factor: 3.162

Review 3.  RNA polymerase II C-terminal domain: Tethering transcription to transcript and template.

Authors:  Jeffry L Corden
Journal:  Chem Rev       Date:  2013-09-16       Impact factor: 60.622

Review 4.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

5.  Structural analysis of the polo-box domain of human Polo-like kinase 2.

Authors:  Ju Hee Kim; Bonsu Ku; Kyung S Lee; Seung Jun Kim
Journal:  Proteins       Date:  2015-04-28

6.  Phase I dose escalation study of NMS-1286937, an orally available Polo-Like Kinase 1 inhibitor, in patients with advanced or metastatic solid tumors.

Authors:  Glen J Weiss; Gayle Jameson; Daniel D Von Hoff; Barbara Valsasina; Cristina Davite; Claudia Di Giulio; Francesco Fiorentini; Rachele Alzani; Patrizia Carpinelli; Alessandro Di Sanzo; Arturo Galvani; Antonella Isacchi; Ramesh K Ramanathan
Journal:  Invest New Drugs       Date:  2017-07-20       Impact factor: 3.850

7.  Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel.

Authors:  Cen Li; Soyoung Park; Xiaowen Zhang; Wei Dai; Dazhong Xu
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

Review 8.  Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.

Authors:  Cayetano Gonzalez
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

Review 9.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

Review 10.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.